MRL Ventures Fund

The MRL Ventures Fund (MRLV) team invests globally in early-stage, preclinical therapeutics companies to transform patient care. The MRL Ventures Fund (MRLV) is the corporate venture arm of Merck & Co., Inc., Rahway, NJ USA, and is located in Cambridge, MA. The MRLV investors do not ask for any product or technology rights as a condition of investment. We do not invest in medical devices, diagnostic platforms, or digital health. Investments -Seed and early-stage company investments -Therapeutics companies—from concept to IND. Investing up to $25 million per company, providing long-term, and committed capital -Lead or join a syndicate of investors and play an active role on company boards -Transparent and streamlined investment process Over the life of the company, the MRLV team will continue to provide capital and expertise. We protect the confidentiality of our current and future portfolio companies by providing a robust firewall from the rest of the corporation. At a portfolio company’s choosing, MRLV investors can act as a conduit to the larger corporate organization to solicit advice/expertise.